Skip navigation

Stay on the Pulse of Emerging Trends in PBM Restrictions

December 13, 2018
  • Philadelphia, PA

As the adoption of copay accumulators and maximizers becomes widespread, so does the need for pharmaceutical manufacturers to ensure a comprehensive understanding of the impact to the commercially insured patient population. CBI’s Copay Accumulator Summit convenes stakeholders from across the life sciences community to discuss the growing trend of cost-shifting pharmacy benefits and strategies to enhance patient access, adherence and financial support.

Realign Access Strategies with Dynamic Discussions on Topics Including:

  • Cost-shifting trends in drug plan benefit design and cost management
  • Stakeholder insights on managing patient access and adherence challenges
  • Strategies to promote patient education and informed discussion
  • Payment technology to manage the impact of copay accumulator programs
  • Cross-departmental perspectives and challenges for manufacturers
  • The future of PBM restrictions, payer access and copay reform

Spark Discussions with Influential Speakers From Companies Including:

AbbVie • BIO • ConnectiveRx • CSRO • EMD Serono • FirstView
Jazz Pharmaceuticals • Multiple Sclerosis Association of America
NASP • Pacific Pharmacy Group • PSI • TrialCard